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Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death in the
world. Radiofrequency ablation (RFA) is an effective method for treating tumors less than 5 cm.
However, manually placing the RFA needle at the site of the tumor is challenging due to the
complicated respiratory induced motion of the liver. This paper presents the design, fabrication,
and benchtop characterization of a patient mounted, respiratory compensated robotic needle
insertion platform to perform percutaneous needle interventions. The robotic platform consists of
a 4-DoF dual-stage cartesian platform used to control the pose of a 1-DoF needle insertion module.
The active needle insertion module consists of a 3D printed flexible fluidic actuator capable of
providing a step-like, grasp-insert-release actuation that mimics the manual insertion procedure.
Force characterization of the needle insertion module indicates that the device is capable of
producing 22.6 ± 0.40 N before the needle slips between the grippers. Static phantom targeting
experiments indicate a positional error of 1.14 ± 0.30 mm and orientational error of 0.99° ± 0.36°.
Static ex-vivo porcine liver targeting experiments indicate a positional error of 1.22 ± 0.31 mm
and orientational error of 1.16° ± 0.44°. Dynamic targeting experiments with the proposed active
motion compensation in dynamic phantom and ex-vivo porcine liver show 66.3% and 69.6%
positional accuracy improvement, respectively. Future work will continue to develop this platform
with the long-term goal of applying the system to RFA for HCC.
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1. Introduction
Primary liver cancer, also known as hepatocellular carcinoma (HCC), is the third most
common cause of cancer-related death in the world with over 700,000 deaths reported annually
[1]. In the United States, an estimated 42,000 adults are diagnosed with liver cancer each year, and
the number of cases is expected to continue to rise due to the increasing number of chronic liver
diseases caused by alcohol, nonalcoholic fatty liver disease, hepatitis B, and hepatitis C infection.
The five-year survival rate for patients is as low as 4% [2]. As a result, there is a considerable
economic loss of upwards of $1 billion per year in the United States [3].
HCC can be treated with a variety of methods. Medical therapy sorafenib provides no
reduction to the mortality rate as it only prolongs survival for a few months [4]. Chemotherapy
fails to provide effective treatment to control tumor growth, primarily due to HCC’s resistance to
radiation [5]. Liver transplantation and partial surgical resection have both been shown to be
effective methods of treatment, however, they both require strict criteria for candidate selection,
thus preventing the majority of diagnosed patients from receiving treatment [6, 7]. Stereotactic
radiosurgery (SRS) is a feasible approach for patients who are not eligible for liver transplantation
or surgical resection [8]; however, randomized clinical trials are still needed to justify its
effectiveness. Thermal therapy, such as radiofrequency ablation (RFA), has been regarded as an
effective method to control tumor growth with an acceptable morbidity rate [9]. The main
advantages of thermal therapy include: 1) minimally invasive with a high safety profile, 2)
capability to enable the focal tumor control, 3) favorable long-term survival rate, and 4) it can be
combined with other treatment approaches [9].
Despite the promising benefits provided by RFA, it does present some clinical limitations,
namely, the precise placement of the RFA needle at the tumor site within the dynamically moving
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liver. This has been a long-standing challenge, even with intra-procedural image guidance. Needle
targeting error is mainly caused by the respiration-induced movement of the liver, which can be as
large as 5.5 cm in the superior-inferior direction [10, 11]. In the manual clinical procedure, errors
as much as 7.4 mm in the longitudinal needle-axis direction and 3.6 mm in the lateral direction
have been reported [12]. To address this issue, breath-holding is typically required during the
placement of the needle to mitigate the motion. However, it can be difficult for patients to hold
their breath due to compromised lung capacity and the significant pain associated with the
radiofrequency ablation procedure [13]. Even with the advent of modern ventilators to induce
active breath control, it is still often more suitable to use free breathing techniques so as to reduce
cost and psychological burden to the patient [14, 15]. Many research groups have proposed robotic
platforms to assist in needle insertion during percutaneous interventions [16, 17]. These designs
can be classified into two categories: 1) the robot only provides needle guidance and 2) the robot
has active needle insertion capability. Examples of the first group include the commercially
available CT-guided robotic positioning system (ROBIO™ EX, Perfint Healthcare Pvt. Ltd,
Florence, OR, USA [18]). Song et al. proposed an MRI compatible double-ring mechanism for
MRI-guided liver interventions [19]. A similar platform was reported by Song and Hata for image
guided cryotherapy of renal cancer [20]. Hata et al. developed a remote-center-of-motion (RCM)
mechanism for MRI-guided microwave therapy [21]. Franco et al. created a 4-DoF robot for MRIguided laser ablation [22]. A serial robot arm (DLR/KUKA Light Weight Robot III) was used by
Tovar-Arriaga et al. to create an FD-CT-guided navigation system for needle placement [23].
Several MRI compatible robotic prototypes have been created by Cleary et al. for percutaneous
shoulder arthrography [24, 25] and for treatment of lower back pain [26]. The second group with
active needle insertion capabilities is made up of the following. Duan et al. designed a robotic
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RCM mechanism on top of a 2-DoF linear slide for RFA of large liver tumors [27]. A robot
developed by Stoianovici known as the AcuBot was also used for percutaneous interventions [28].
In addition to these two robots, several autonomous 1-DoF needle insertion robots were developed
that focus on the tissue-needle mechanics modeling [29-34]. These robots have shown promise;
however, none address the issue of respiration-induced organ motion as most of the accuracy tests
were performed in a static phantom or cadaver. Several groups have developed motion prediction
algorithms or robot-tissue interaction models to compensate for liver motion, such as the weightedfrequency Fourier linear combiner algorithm [35], iterative learning control method [36], and
impedance and admittance control approaches [37, 38]. However, these methods rely on
complicated modeling or oversimplified assumptions, thus none have been used in clinical trials
to the best of our knowledge.
In this work, we propose the design and evaluation of a novel patient-mounted
percutaneous needle insertion robot that mimics the current clinical practice by inserting the RFA
needle in accordance with the patient’s respiratory motion. This robot is intended to enable
accurate ablation needle placement under CT-guidance. Our work is innovative in terms of the 1)
active motion compensation protocol, 2) stepwise needle insertion to ensure safety, 3) precise
needle position and orientation deployment. These innovations should make our robot safer and
more convenient to perform CT-guided RFA for HCC treatment. Our contributions include: (1)
the design and modeling of a minimally invasive needle guidance and insertion robot, (2) force
modeling of the needle insertion module, and (3) extensive robot validations in static and dynamic
phantom and ex-vivo tissue.
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2. Methods
2.1. Mechanical Design Overview
The robot consists of three major subsystems: (1) a lower stage with a motorized cartesian
carriage, (2) an identical upper stage, and (3) an active needle insertion module that connects both
stages together. The upper and lower stages have carriages that are capable of being translated in
both x- and y-directions to provide 2-DoF translation. The carriages both have spherical bearings
set into them that support the needle insertion module. By changing the relative location between
these bearings, 2-DoF orientation of the needle insertion module can be controlled. The needle
insertion module provides 1-DoF bidirectional translation of the ablation needle using a custom
3D-printed flexible fluidic actuator. The entire robot is then housed within a 3D-printed Z-frame
for the purposes of coordinate frame registration within the CT-scanner [39]. The robot is designed
to be mounted directly to the patient to passively compensate for respiratory motion by allowing
the robot to move up and down with the patient during periods of respiration. The Z-frame is
designed with slots for the placement of adjustable straps to fix the robot according to patient
comfort, as seen in the model of the robot in Fig. 1. The adjustable straps allow the robot to be
positioned in virtually any position the clinicians deem necessary to reach the target based on
preoperative planning. The overall dimensions of the robot are 216 mm × 210 mm × 130 mm with
a total weight of 2.17 kg, ensuring a compact design such that the patient can comfortably fit within
the CT bore with the robot. Table 1 presents the main robot properties. Note that while this
prototype is sufficiently lightweight (less than 3 kg) to ensure patient comfort [40], it is only a
proof-of-concept to evaluate the proposed motion compensation protocol. The weight can be
further reduced by using lightweight 3D printed pneumatic motors [41] and replacing the metal
components with carbon fiber materials.

4

Fig. 1. CAD model of the liver ablation robot mounted on the patient within CT scanner.

Table 1 Robot Properties Based on Design and Workspace Analysis
Robot Dimensions

216 mm × 210 mm x 130 mm

Active DoF

5

x-y Displacement

75 mm x 70 mm

Insertion Depth

Limited by Needle Length

Orientation about x and y axes

± 15◦

Weight

2.17 kg

2.2. 4-DoF Cartesian Stages
The upper and lower motorized cartesian stages are based on a custom-designed CoreXY
system [42-44], shown in Fig. 2. The system design takes advantage of two statically positioned
stepper motors and provides a means of translating both axes independently or simultaneously.
The stationary motors have the added benefit of reducing the number of moving parts, increasing
the acceleration capabilities of the robot, maintaining a constant center of gravity, and allowing
for a more compact design to be implemented.

5

The carriages are driven by a timing belt attached to the output shafts of four bipolar NEMA
11 stepper motors and the acrylic base frame using friction-reducing pulleys. The motor speeds
are limited to 10 mm/s to avoid high accelerations and loss of steps. While these stepper motors
are not back drivable under their holding torque, the motion compensation protocol was primarily
achieved by the 3D-printed needle insertion module to allow for needle movement in the event of
liver motion. Limit switches are used to set the home position of the carriages. Bearing housings,
shaft couplers and the carriages themselves are 3D printed using acrylonitrile butadiene styrene
(ABS). The low-level control of the cartesian stages is done on a microcontroller (ATmega 2560)
with its supporting circuit. The two stages are fixed parallel to each other and held in place by
support tabs attached to the fiducial registration Z-frame.

Fig. 2. (Left) CoreXY mechanism of one of the cartesian stages, (Right) CAD model showing
the stages connected in parallel via the Z-frame.

2.3. Forward and inverse Kinematics
Inspired by the similarities in dual cartesian platforms as demonstrated by Li et al. in [26],
a similar approach to solving the kinematics problems was taken. The coordinate frames, 𝐹𝑢𝑝𝑝𝑒𝑟
and 𝐹𝑙𝑜𝑤𝑒𝑟 , for the upper and lower stages are defined identically as being at the center of the
spherical bearings in the carriages when both stages are in the homed position as seen in Fig. 3.
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The positions of the center of the upper and lower carriages are denoted by 𝑂𝑢𝑝𝑝𝑒𝑟 = (𝑥𝑢 , 𝑦𝑢 , 𝑧𝑢 ),
and 𝑂𝑙𝑜𝑤𝑒𝑟 = (𝑥𝑙 , 𝑦𝑙 , 𝑧𝑙 ) respectively. The x and y positions of the carriages can be written in terms
of the equations of motion governing the CoreXY mechanism that relate motor rotation ∆𝐴 and
∆𝐵 to translation, given by
∆𝑥 = 1/2 (∆𝐴 + ∆𝐵)

(1)

∆𝑦 = 1/2 (∆𝐴 − ∆𝐵)

(2)

The forward kinematics of the robot takes the joint space positions [𝑥𝑢 , 𝑦𝑢 ], [ 𝑥𝑙 , 𝑦𝑙 ] along
with the desired needle insertion depth, 𝑙, and solves for the position of the tip of the needle, in
addition to the needle axis vector. The positions of the center of the carriages would then be
defined as 𝑂𝑢𝑝𝑝𝑒𝑟 = (𝑥𝑢 , 𝑦𝑢 , 0) and 𝑂𝑙𝑜𝑤𝑒𝑟 = (𝑥𝑙 , 𝑦𝑙 , −𝐻), where 𝐻 is the constant distance
̂ , defining
maintained between the two parallel stages of the cartesian platform. The unit vector, 𝑁
the axis of the needle could then be given by the normalized vector of the difference between the
positions of the center of the upper and lower carriages. Using this needle axis vector, we can then
solve for the position of the of the tip of the needle, 𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 , using the insertion depth. The
̂ and 𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 are
equations defining 𝑁
̂=
𝑁

𝑂𝑙𝑜𝑤𝑒𝑟 − 𝑂𝑢𝑝𝑝𝑒𝑟
‖𝑂𝑙𝑜𝑤𝑒𝑟 − 𝑂𝑢𝑝𝑝𝑒𝑟 ‖

̂
𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 = 𝑂𝑙𝑜𝑤𝑒𝑟 − 𝑙𝑁

(3)

(4)

The robot workspace was simulated in Matlab across the achievable translations in the x- and ydirections of the cartesian stages described previously in Table 1. The blue dots in Fig. 3. show the
workspace of the robot and it is overlaid with an average adult human liver. Comparing the volume
of the workspace to that of an average adult human liver, the robot can reach 70% of the volume
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of an average adult human liver when placed directly above it. Note that the 70% value is just a
comparison of the robot workspace to the total size of the average liver.
The inverse kinematics of the robot is used to solve for the joint space positions 𝑥𝑢 , 𝑦𝑢 , 𝑥𝑙
and 𝑦𝑙 along with the required needle insertion depth, 𝑙, given the desired needle tip position,
𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 = (𝑇𝑥 , 𝑇𝑦 , 𝑇𝑧 ), and the needle entry point, 𝑃𝑒𝑛𝑡𝑟𝑦 = (𝑃𝑥 , 𝑃𝑦 , 𝑃𝑧 ), within the global
coordinate frame. The needle vector axis can be defined by
𝑁 = 𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 − 𝑃𝑒𝑛𝑡𝑟𝑦

(5)

Using 𝑁 = (𝑁𝑥 , 𝑁𝑦 , 𝑁𝑧 ), we can then solve for the positions of the center of the carriages needed
to generate this needle axis vector given by,

𝑥𝑢 = 𝑇𝑥 −

𝑇𝑧 + 𝐻
𝑁𝑥
𝑁𝑧

(6)

𝑦𝑢 = 𝑇𝑦 −

𝑇𝑧 + 𝐻
𝑁𝑦
𝑁𝑧

(7)

𝑥𝑙 = 𝑇𝑥 −

𝑇𝑧
𝑁
𝑁𝑧 𝑥

(8)

𝑦𝑙 = 𝑇𝑦 −

𝑇𝑧
𝑁
𝑁𝑧 𝑦

(9)

The insertion depth of the needle, 𝑙, is solved for by finding the Euclidean distance between the
desired entry point and the location of the desired target,
𝑙 = ‖𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 − 𝑃𝑒𝑛𝑡𝑟𝑦 ‖

(10)

In the clinical workflow the point 𝑃𝑒𝑛𝑡𝑟𝑦 will be defined by the clinician based on pre-operative
imaging. The robot forward and inverse kinematics were implemented in a custom Matlab GUI,
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whereby 𝑇𝑑𝑒𝑠𝑖𝑟𝑒𝑑 and 𝑃𝑒𝑛𝑡𝑟𝑦 could be input and the coordinates of the upper and lower carriages
are solved for to generate the appropriate needle vector axis. These joint space positions in addition
to the needle insertion depth are then communicated to the robot over a serial bus to the low-level
microcontroller such that the robot can be aligned to the desired location.

Fig. 3. Coordinate frame assignment of the patient mounted robot. Forward kinematics indicates
that the robot workspace (blue point cloud) is able to cover 70% of the liver.

2.4. Active Needle Insertion Module
The active needle insertion module utilizes a modified, more compact design based on an
MR-compatible needle driver developed by Comber et al. [45]. The modifications made include:
1) The needle insertion module dimension has been significantly reduced from Φ 8.9 𝑐𝑚 × 33 𝑐𝑚
to Φ 5.8 𝑐𝑚 × 7 𝑐𝑚 such that the robot can be operated within the CT scanner. This is achieved
by using only 2 linear bellows, using a single gripper, and eliminating the rotation bellow, and 2)
9

The insertion force was theoretically modeled and experimentally validated in order to guarantee
that the design could generate the forces necessary to penetrate tissue. The design consists of two
key components that allow for 1-DoF needle translation: (1) the linear bellow actuator and (2) the
gripper. The mechanism is also referred to as a flexible fluidic actuator (FFA) since both
components are actuated using pressurized air. The linear bellow actuator consists of a toroidal
bellow geometry such that the hollow center can be used to translate the needle through the
device’s central axis. Under operation, the needle can be grasped using the gripper mechanism,
which consists of two flat diaphragms that when inflated, expand to grasp the needle. The FFA,
seen in Fig. 4a, was 3D printed in the material nylon-12 using selective laser sintering (SLS).
Safety tabs (see Fig. 4b) were added to the design to restrict the linear translation of the mechanism
to < 2mm. The concept of safety tabs is crucial to ensure safe operation of the device to within
only one full step of the FFA in the event of a system failure. The FFA is housed within a 3D
printed housing, as seen in Fig. 4b, that consists of mechanical stop brackets to restrict the linear
displacement of the FFA to a step size of 1.5 mm. Attached to the housing is an optical encoder
(US-Digital part no. EM1-1-500-N), and a linear transmissive strip (500 lines per inch) is mounted
to the safety tab on the FFA. This is done so that the relative displacement between the housing
and FFA could be measured to determine the insertion or retraction depth of the needle. The FFA
was controlled using two proportional directional control valves (Festo MPYE-5-M5-010-B) with
the control signal supplied via a microcontroller (ATmega 2560) and amplifier circuit.
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Fig. 4. (a) SLS 3D printed flexible fluidic actuator with attached linear transmissive strip, (b)
CAD model of the flexible fluidic actuator, its housing with mounted linear optical encoder

2.5. Active Motion Compensation Protocol
An active motion compensation protocol is proposed for operating the patient mounted
robot. In this protocol, the ablation needle will be automatically deployed towards the liver tumor
during the stationary phase of the respiration cycle. The stepwise “move-pause” insertion protocol
is inspired by the manual insertion procedure, whereby the clinician typically inserts the needle
when the liver has the least motion and releases the needle when respiration induced motion is
significant. The respiratory cycle of the patient will be gated using the GE D690 PET/CT scanner
which uses the Varian CT Real-Time Position Management system (Varian Medical Systems, Palo
Alto, CA). The Real-Time Position Management system consists of reflectors attached to an
external marker placed on the patient’s abdomen [46]. The marker motion reflects the breathing
pattern of the patient and can be captured by an external camera at a frequency of 30 Hz [47] to
obtain a surrogate respiratory signal. The system is able to track the real-time position data even
when the respiratory rate changes suddenly. The needle insertion module must complete a fullstep insertion when the liver has negligible movement in its static phase and release the needle
11

when the liver undergoes significant movement during its dynamic phase. In order to achieve this
protocol, the insertion sequence is divided into four sequential steps: grasp, insert, release, and
home. Fig. 5a shows the finite element method (FEM) simulation of the FFA motion subject to
the pressure input. Retracting the needle can be achieved by alternating the sequence to power the
FFA. Note that the operation process must be completed within about 2s to cover just the static
phase as seen in Fig. 5b. The current prototype of the needle insertion module is capable of
inserting the needle at a maximum speed of 1.5 mm/s.

Fig. 5. (a) Illustration of the sequential step-like grasp-insert-release method of actuation of the
needle insertion module. The linear bellow will be depressurized to the home position after the
release step. (b) static and dynamic phases of an in-vivo porcine liver

2.6. Robotic RFA Clinical Workflow
In the proposed clinical workflow, the patient will be positioned in the GE D690 PET/CT
scanner and the robot will be fixed to the patient’s abdomen using adjustable straps. An initial CT
scan will be performed to register the robot to the CT scanner using the point-based registration
method [44]. A second CT scan will be used to identify the desired target location, which will be
12

used by the radiologist to determine an appropriate needle entry point. The robot will automatically
align the needle insertion module to the desired target and the needle can then be progressed
towards the ablation target. During the needle insertion process, the Varian CT Real-Time Position
Management system will continuously track the patient’s respiratory cycle. According to the
proposed motion compensation protocol, the needle is only advanced when the liver has the least
amount of motion (static phase, see Fig. 5b). Once the needle is placed at the target location, a
confirmation scan will be conducted to verify the needle location, and ablation therapy will then
be performed. The detailed workflow is shown in Fig. 6.

Fig. 6. The proposed clinical workflow of the robot
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2.7. Force Modeling of the Needle Insertion Module
In this section, we focus on the force modeling of the FFA to estimate the force the FFA is
capable of inserting a needle with. According to [48], the axial force of the linear bellows, 𝐹𝐴 , is
given by,
𝐹𝐴 = 𝜋(𝑅 + ℎ)2 𝑥𝑃

𝑥=

(11)

(1 − 𝜌2 )(1 − 𝜌4 + 4𝜌2 ln 𝜌)
4(1 − 𝜌2 + 2𝜌 ln 𝜌)(1 − 𝜌2 − 2𝜌 ln 𝜌)

(12)

𝑅−ℎ
𝑅+ℎ

(13)

𝜌=

The parameter 𝑅 defines the mean radius of the bellow, and ℎ is half the wave height of a
corrugation, as depicted in Fig. 7. In addition to this axial force caused by the linear bellows, the
force of friction that the gripper is holding the needle with plays a key role in determining the
needle insertion force and should be considered. From a review of the principles from mechanics
of materials [49], the deflection of a thin circular plate with clamped outer edges and a free inner
edge is given by

𝑦𝑚𝑎𝑥 =

𝑃𝑎4
64𝐷

(14)

where 𝑃 is a uniformly distributed pressure over the surface area of the diaphragm, 𝑎 is the radius
of the diaphragm, and 𝐷 is the flexural rigidity defined in (15) as
𝐸𝑡 3
𝐷=
12(1 − 𝜈 2 )
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(15)

where 𝐸 and ν are the material properties Young’s modulus and Poisson’s ratio, respectively, and

t is the thickness of the diaphragm. Again, from mechanics of materials, we can derive the normal
force, 𝐹𝑁 , acting on the needle due to the deflection of the diaphragms. The relationship between
the normal force and the displacement at the center of the diaphragm is given by,

𝑦𝑚𝑎𝑥

𝐹𝑁 𝑎2
=
16𝜋𝐷

(16)

Substituting (14) and (15) into (16) we then have a relationship between the input internal pressure
of the diaphragm chamber and the normal force generated between the diaphragms and the needle.
A scaling factor of 2 is included since the normal force is being applied to both sides of the needle.
This relationship is given by,
𝐹𝑁 =

𝜋 2
𝑃𝑎
2

(17)

Using this normal force to pressure relationship, we can then estimate the force of friction holding
the needle in place by multiplying the normal force by the coefficient of friction, 0.35, of the
material. For an input pressure of 345 kPa, an estimated 24.6 N of friction force will be used to
clamp onto the needle. This force is considered as more than sufficient for percutaneous needle
interventions [50-52].
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Fig. 7. Parameters used in force estimation and analysis
3. Experiments and Results
Several experiments were conducted to characterize the performance of the robot: a) freespace accuracy evaluation of the 4-DoF dual cartesian stages, b) free-space accuracy and
repeatability of the needle insertion module, c) force characterization of the needle insertion
module, d) static phantom and static ex-vivo porcine liver tissue targeting, e) dynamic phantom
targeting, and f) dynamic ex-vivo porcine liver tissue targeting.
3.1. Accuracy analysis of the dual cartesian stages
To characterize the accuracy of the dual cartesian stages, a free-space analysis was
conducted. This was done using the Aurora electromagnetic (EM) tracking system (NDI Medical,
Ontario, Canada) with resolution of 0.5 mm. The two carriages were linked together, allowing the
central axis between the two carriages to be more easily identified. A 5-DoF EM sensor was used
to track the position of the central axis between the carriages. Coordinate registration was done to
be able to track the sensor within the robot reference frame using the point-based registration
method [53]. The reference frame registration was taken after initially homing both stages of the
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robot. From there, a desired path was sent to the robot via the Matlab GUI and the real time position
was tracked. The desired paths consisted of four squares of length 10 mm, 20 mm, 30 mm, and 40
mm, all created by streamlining the coordinates of the corners of the square to the GUI as seen in
Fig. 8. The mean error across three experiments for each desired path was measured at the corners
of the squares in both the x- and y-directions. The mean error in the x-direction is 0.18 ± 0.18 mm
and the mean error in the y-direction is 0.32 ± 0.23 mm. These free-space experimental results
were taken as validation for sufficient accuracy of the dual cartesian system to potentially be used
for precise needle placement operations.

Fig. 8. Desired path versus the actual tracked path of the Cartesian stages. The dashed lines
represent the desired path while the dots show the data collected from the EM tracker
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3.2. Accuracy and Repeatability of needle insertion module
To characterize the accuracy of the needle insertion module, the EM tracker was again used
to perform insertion in free space. An EM sensor was attached to the tip of a needle and a custom
3D printed bracket was used for coordinate registration. The needle used was an 18-gauge needle
with diamond shaped tip. Eight insertion depths of 15 mm, 30 mm, 45 mm, 60 mm, 75 mm, 90
mm, 105 mm and 120 mm were sent to the needle insertion module from the GUI for a total of
three iterations for each depth. The error was considered to be the difference between the measured
insertion depth and the desired depth. The mean error across all 24 experiments was found to be
0.64 ± 0.38 mm (see Table 2 for the error results at each insertion depth). Note that the error does
not accumulate as the needle insertion depth is increased due to the step-wise operation of the
needle insertion module. This step-wise insertion ensures that the needle insertion error is within
one full step-size of the FFA (1.5 mm). The repeatability of the needle insertion module was
quantified by evaluating the Coefficient of Variation (CV) [41, 54]. The CV is expressed as a
percentage, and the lower the percentage, the better the repeatability is. The results of the needle
insertion experiment are presented in Table 2.
Table 2 Needle Insertion Accuracy and Repeatability
Desired Insertion
Depth (mm)

Mean Measured
Depth (mm)

|Mean Error|
(mm)

15
30
45
60
75
90
105
120
Mean

15.94
30.49
44.97
60.26
76.12
90.40
105.17
120.16

0.94
0.49
0.23
0.84
1.12
0.56
0.56
0.36
0.64
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STD of the
Measured Depth
(mm)
0.10
0.19
0.25
0.80
0.51
0.49
0.54
0.43
0.38

CV %
0.62
0.61
0.55
1.33
0.67
0.54
0.51
0.36
0.65

3.3. Force characterization of needle insertion module
In addition to the insertion testing accuracy in free-space, the forces generated by the FFA
were also characterized. The insertion force due to pressurizing the linear bellows was found by
placing a force sensor (Vernier Go Direct® Force and Acceleration Sensor) with a flat plate adapter
directly against the FFA as seen in Fig. 9(a). The pressure inside the linear bellows was slowly
increased from 0 kPa to 110 kPa, corresponding to the maximum force measurable by the force
sensor. As the pressure was increased, the insertion force was recorded at intervals of 17.5 kPa
(2.5 psi). A custom 3D printed bracket was designed to attach the safety tabs on the FFA to the
force sensor. It was configured such that the linear bellows could be pressurized and allow the
pulling, retraction force of the bellows to be measured as they were depressurized, as seen in Fig.
9(b). As the pressure was decreased, the corresponding retraction force was recorded for the same
intervals as previously mentioned. The results of the linear bellows force characterization were
compared to the predicted forces calculated using (11) - (13) in Section II-C as seen in Fig. 10(a)
and (b). A mean error of 2.57 ± 0.6 N was found for the insertion force experiment and a mean
error of 4.04 ± 1.39 N was found for the retraction force experiment. . These errors can be largely
attributed to manufacturing imperfections in the FFA.
The linear bellows are capable of producing significantly more force than the gripping
diaphragms at the same pressure input, therefore we expect the needle to slip between the
diaphragms at a certain point. To characterize this frictional force, the FFA was set up as seen in
Fig. 9(a), but rather than having the force sensor pressed up against the FFA, a needle was placed
between the grippers at 345 kPa and the force sensor then positioned at the tip of the needle. The
pressure inside the linear bellows was then increased and the force at the tip of the needle was
monitored. A noticeable peak force was achieved which corresponded to the needle beginning to

19

slip due to the change from static friction to dynamic friction, as seen in Fig. 10(c). Based on the
calculations in Section II-C a peak force of 24.6 N was expected, while the experimental results
indicate a mean peak force of 22.6 ± 0.40 N across three trials. This difference of 8.4% may be as
a result of manufacturing imperfections and environmental conditions affecting the coefficient of
friction between the two materials. The linear bellows force characterization and the friction force
analysis both indicate more than sufficient force is achievable to perform percutaneous liver
interventions, where a peak force of about 6 N was recorded for the percutaneous interventions
based on previously mentioned research.

Fig. 9. Experimental setup for the linear bellows characterization, (a) characterization of the FFA
insertion force, (b) characterization of the FFA retraction force
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Fig. 10. Results of the FFA characterization: (a) insertion force characterization results, (b)
retraction force characterization results, (c) experimental friction force between the gripper and
the needle as the pressure input to the linear bellows is increased compared to the theoretical
peak friction force with the pressure input of 345 kPa to the gripper mechanism.

3.4. Robot Targeting Test: Static phantom and ex-vivo porcine liver trial
A 5% by volume agar gelatin phantom was created to mimic soft liver tissue. The
experiment was conducted by selecting 24 arbitrary points, grouped into four groups of 6 points,
within the robot’s workspace and using their xy-location as the desired target. For the first group
of six points, the desired insertion depth was increased from 15 to 90 mm in 15 mm increments
across the points and the needle orientation was set to 0°. This was then repeated for the remaining
three groups however the needle orientation about the x-axis was increased in 5° increments across
the groups. Using these values as the desired input to the robot GUI, the needle was placed and
automatically deployed to the phantom via the needle insertion module. The final location of the
needle was recorded by the EM tracker. Each targeting experiment was conducted three times and
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the mean values were used in quantifying the accuracy of the robot. The positional error was
defined to be the Euclidean distance between the desired target and the measured location.
Additionally, the orientational error is defined by the difference between the desired input angle
and the measured angle. The results for the static phantom experiment show that there is a mean
positional error of 1.14 ± 0.30 mm and an orientational error of 0.99° ± 0.36°.
The same points and grouping scheme were used to repeat the experiment in a static exvivo porcine liver except the insertion depth increased from 10 to 60 mm in increments of 10 mm,
where 60mm was the maximum thickness of the porcine liver sample used. Porcine liver has often
been used to mimic an environment for testing needle insertion devices in place of human tissue.
The porcine liver was acquired fresh from a local meat supplier, and prior to testing the liver was
allowed to come to room temperature. The results show that there is a mean positional error of
1.22 ± 0.31 mm and an orientational error of 1.16° ± 0.44°. A top view of the static targeting
experiments can be seen in Fig. 11. There is a slight increase in positional targeting error of the
needle with respect to the insertion depth in both the static phantom and ex-vivo liver trials. This
can be seen in Fig. 12 where there is a general increasing trend in the positional error as the
insertion depth is increased. The targeting error, however, does not show any significant statistical
relation to the increasing inclination of the needle.
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Fig. 11. Top view of the static targeting experiments. The blue circles represent the desired target
location, the red stars show the measured needle position in the static phantom, and the green
stars show the measured needle position in the static ex-vivo porcine liver.

Fig. 12. (a) Static phantom needle targeting error vs. insertion depth (b) Static ex-vivo porcine
liver needle targeting error vs. insertion depth. In both tests, the needle insertion angle was
increased from 0° to 15° in increments of 5°.
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3.5. Robot targeting: Dynamic phantom trial
To validate the robot’s targeting performance under the dynamic conditions of the liver, a
dynamic motion platform was developed to create a relative displacement between the robot and
the phantom. The motion platform consists of two stepper motor driven linear rails fixed to one
another perpendicularly in the horizontal plane as seen in Fig. 13. A two-dimensional dynamic
phantom was chosen rather than considering three-dimensional motion for two primary reasons.
Based on our previous research [55], liver motion in the inferior-superior (I-S) and left-right (LR) is dominant in comparison to the motion generated in the posterior-anterior (P-A) direction (~
1.2 mm). A two-dimensional dynamic motion platform also greatly simplified the robotic motion
platform, especially during the prototype characterization period. Between every two steps of the
needle insertion process, the motion platform moves the phantom 10mm in the x-direction and
5mm in the y-direction to simulate the respiratory induced motion of the liver in the I-S direction
and L-R direction, respectively. While the phantom is in motion, the needle insertion module
releases the needle to allow it to move with the phantom freely. Once the platform has returned to
its original position, the needle insertion module takes another two full insertion steps and the
process is repeated until the needle has reached its final target. The stepwise “move-pause”
insertion protocol is inspired by the manual insertion procedure, where the clinician typically
inserts the needle when the liver has the least motion and releases the needle when respiration
motion is significant. Twenty-four targets were selected by arbitrarily inserting the 6-DoF EM
tracking probe (NDI Medical, Ontario, Canada) into the phantom. The location of the target, the
tip of the EM tracking probe, was then converted into the robot frame and used as an input for the
GUI. Similar to the static phantom trial, the 24 points were grouped into 4 groups of 6 and the
desired insertion depth of the needle was user controlled from 15 to 90 mm in 15 mm increments
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while the needle orientation across each group was increased from 0° to 15° in increments of 5°.
Three insertion trials were conducted for each target and the error for these dynamic targeting
experiments is defined to be the same as in the static experiments. The results of the dynamic
targeting experiments in phantom indicate a mean positional error of 1.69 ± 0.66 mm and a mean
orientational error of 1.66 ± 0.50°.

Fig. 13. Experimental setup of the dynamic phantom experiments. The green arrows indicate the
directions of motion of the platform that creates the 2-DoF translation of the phantom. The CAD
model of the robot is overlaid on the image for clarity.

The dynamic targeting experiments were repeated, however, this time no motion
compensation was considered. The synchronicity between the needle insertion module and the
motion platform was disabled so that there was no consideration of the location of the moving
target with respect to the insertion of the needle. The needle was inserted with constant speed until
it reached its final target, the motion platform was simultaneously stopped, and the final needle
position was recorded. The results of this dynamic targeting experiment with no motion
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compensation indicates a mean positional error of 5.02 ± 2.35 mm and a mean orientational error
of 4.54 ± 1.40°. A comparison between the dynamic phantom targeting experiments with active
motion compensation and without motion compensation is shown in Fig. 14.

Fig. 14. Comparison of dynamic phantom targeting experiments with and without active motion
compensation

3.6. Robot targeting: Dynamic ex-vivo porcine liver trial
To simulate targeting in biological tissue, an ex-vivo porcine liver sample was used in place
of the agar phantom. The same workflow used in the dynamic phantom targeting experiments was
employed here for a total of 24 targets. With the motion compensation protocol implemented, the
results indicate a mean positional error of 1.54 ± 0.55 mm and a mean orientational error of 1.68
± 0.47°. The experiments were repeated without the motion compensation protocol implemented
and the results show a mean positional error of 5.07 ± 2.44 mm and a mean orientational error of
4.06 ± 1.45°. A comparison of these results is presented in Fig. 15. Similar to the static
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experiments, a slight increase in positional targeting error was observed in both the phantom and
ex-vivo liver trials, more noticeably in the ex-vivo liver as seen in Fig. 16. Again, no noticeable
statistical correlation could be made between targeting error and increasing inclination of the
needle.

Fig. 15. Comparison of ex-vivo porcine liver dynamic targeting experiments with and without
active motion compensation
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Fig. 16. (a) Dynamic phantom needle targeting error vs. insertion depth (b) Dynamic ex-vivo
porcine liver needle targeting error vs. insertion depth. In both experiments, the needle insertion
angle was increased from 0° to 15° in increments of 5°.

4. Discussion and Conclusion
This paper presents the design, fabrication, and preliminary benchtop characterization of a
5 DoF, patient mounted robot to perform percutaneous needle interventions for the treatment of
hepatocellular carcinoma. The robot includes a dual cartesian platform with a custom 3D printed
active needle insertion module and is designed to be directly mounted onto the patient’s abdomen.
With the step-wise needle insertion module, an active motion compensation protocol is proposed
to further reduce any targeting errors that may be caused by the respiratory induced motion of the
liver.
The system was first analyzed on an individual subsystem level to validate the accuracy of
that specific component before moving on to complete system testing. In free-space testing, the
accuracy of the dual cartesian platform was shown to have a mean error of 0.18 ± 0.18 mm in the
x-direction, and a mean error of 0.32 ± 0.23 mm in the y-direction. Additionally, in free-space
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testing, the needle insertion module demonstrated needle insertion accuracy of 0.64 ± 0.38 mm
mm along the axis of the needle, with good repeatability indicated by an average CV of 0.65%.
Force characterization experiments showed sufficient force generation from the needle insertion
module to perform percutaneous needle interventions. The submillimeter accuracy of these two
metrics and the force requirement being met was taken as validation of the main subsystems and
warranted further analysis of the robot.
In the static phantom targeting experiments, the mean positional error was demonstrated to
be 1.14 ± 0.30 mm, and the mean orientational error was found to be 0.99 ± 0.36°. Additionally,
in the static ex-vivo liver targeting experiments, the mean positional error was demonstrated to be
1.22 ± 0.31 mm, and the mean orientational error was found to be 1.16 ± 0.44°. This served as a
benchmark for the dynamic targeting experiments. In the next stages of testing, the dynamic
motion of the liver was simulated by a phantom mounted to a dynamic platform. Using the protocol
of only inserting the needle during the stationary period of the phantom’s trajectory gave similar
results to the static phantom experimentation with mean positional error of 1.69 ± 0.66 mm and
mean orientational error of 1.66 ± 0.50°. This was then compared to experiments that did not
consider the motion compensation strategy where there is noticeably large variance in the results
and high positional error and orientational error. We see a 66.3% improvement in positional
accuracy when the active motion compensation protocol is implemented versus when it is not. The
dynamic experiments were once again repeated, however in an ex-vivo porcine liver to recreate
insertion into biological tissue. The results of this experiment show a mean positional error of 1.54
± 0.55 mm and a mean orientational error of 1.68 ± 0.47°. Similar to the dynamic phantom
experiments, with the motion compensation protocol implemented the results showed a 69.6%
improvement in positional accuracy over those trials that did not implement the motion
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compensation protocol. The lack of active motion compensation gave way to high variance, high
positional and high orientational errors.
The errors seen in these experiments can be attributed to fabrication deviations and
registration errors. Manufacturing errors lead to misalignment of the upper and lower Cartesian
stages, and while calibration measures were taken to account for this, other sources of errors may
have arisen from backlash in the timing belts, and flexion in the acrylic and 3D printed
components. Additional fabrication errors can be attributed to the deviations seen between the
force characterization experiments and the predicted values. Improvements could be made to
minimize errors in fabrication such as using high precision machined components rather than 3D
printed parts and leadscrews with anti-backlash systems in place. Closed-loop motors could also
be used to account for losses in steps.
The implementation of a robotic platform as proposed in this study could potentially lead
to the safer and more efficient treatment of HCC. This first characterization study serves as a
critical first step to providing precise needle placement within the dynamic environment of the
abdominal region. In future work, radiolucent and more lightweight materials such as carbon fiber
rods and 3D printed pneumatic motors will be used in place of the metallic components used in
this current prototype. To increase the workspace of the robot by allowing for greater inclination
of the needle insertion module, custom spherical bearings will be used in future iterations of this
robotic platform. Additionally, a haptic feedback master device will be developed to allow the
clinician to sense the needle insertion forces throughout the procedure. Further work will be done
to analyze the robot’s performance within the CT Scanner, to implement closed-loop control with
CT Real-Time Position Management feedback and to evaluate the robot’s performance in animal
trials.
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